
China Hemodialysis and Peritoneal Dialysis Market Report and Forecast 2025-2034
Description
The hemodialysis and peritoneal dialysis market in China was valued at USD 7.18 Billion in 2024, driven by increasing cases of end-stage renal disease. The market is anticipated to grow at a CAGR of 9.30% during the forecast period of 2025-2034, with values likely to reach USD 17.47 Billion by 2034.
Hemodialysis and Peritoneal Dialysis: Introduction
Peritoneal dialysis and hemodialysis are alternatives for dialysis for patients with end-stage renal disease in whom preventive kidney transplantation is not possible. Hemodialysis is performed through a machine that filters the body’s blood and toxins through a dialyzer (also known as an artificial kidney). In peritoneal dialysis, the tiny blood vessels inside the abdominal lining filter blood with the help of a dialysis solution.
China Hemodialysis and Peritoneal Dialysis Market Analysis
The China hemodialysis and peritoneal dialysis market value is being driven by factors like growing ESRD patients, increasing prevalence of diabetes and high blood pressure, and the growing number of dialysis facilities across the country. The growing preference for dialysis treatments among consumers owing to the risk associated with kidney transplants is expected to aid the industry growth over the forecast period.
With the help of increasing mergers and partnerships between native and international companies, the region is witnessing a notable emphasis on integrating new solutions to offer better patient alternatives. Japan based Terumo Corporation and WEGO Terumo (Weihai) Medical Products CO., Ltd., received the National Medical Products Administration (NMPA) approval to market and manufacture the first neutralized peritoneal dialysis solution in the country. Such partnerships play a critical role in fueling the hemodialysis and peritoneal dialysis market growth.
The growing convergence of digital and artificial intelligence enabled devices is also expected to boost market growth. With government and private initiatives, there is high emphasis on educating the healthcare professionals to properly use modern technology.
China Hemodialysis and Peritoneal Dialysis Market Segmentation
The EMR’s report titled “Hemodialysis and Peritoneal Dialysis Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Type Conventional Hemodialysis
Daily Hemodialysis
Nocturnal Hemodialysis Continuous Ambulatory Peritoneal Dialysis (CAPD)
Automated Peritoneal Dialysis (APD)
Market Breakup by Product and Services Dialysis Machines
Dialyzers
Bloodline Systems
Others Catheters
Peritoneal Dialysis Solution
Bloodline Tubing Sets
Others
The China hemodialysis and peritoneal dialysis market demand is being driven by the rising health concerns among consumers, the growing disposable incomes, and the rapidly emerging economies within the region. With the advent of minimally invasive tools, the patient volume has been relatively higher owing to convenient procedures and faster recovery period.
With a significant rise in healthcare investments, there has been a notable increase in the number of dialysis centers in China. The segment of hemodialysis will hold the largest share in the market, primarily due to greater accessibility of HD centers, an increasing number of public dialysis centers, increased knowledge and understanding of the management of HD, reimbursement coverage, and socio-demographic factors. In addition, the growing focus of key players for expanding their business in the country will boost the hemodialysis and peritoneal dialysis market share globally as well.
China Hemodialysis and Peritoneal Dialysis Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Hemodialysis and Peritoneal Dialysis: Introduction
Peritoneal dialysis and hemodialysis are alternatives for dialysis for patients with end-stage renal disease in whom preventive kidney transplantation is not possible. Hemodialysis is performed through a machine that filters the body’s blood and toxins through a dialyzer (also known as an artificial kidney). In peritoneal dialysis, the tiny blood vessels inside the abdominal lining filter blood with the help of a dialysis solution.
China Hemodialysis and Peritoneal Dialysis Market Analysis
The China hemodialysis and peritoneal dialysis market value is being driven by factors like growing ESRD patients, increasing prevalence of diabetes and high blood pressure, and the growing number of dialysis facilities across the country. The growing preference for dialysis treatments among consumers owing to the risk associated with kidney transplants is expected to aid the industry growth over the forecast period.
With the help of increasing mergers and partnerships between native and international companies, the region is witnessing a notable emphasis on integrating new solutions to offer better patient alternatives. Japan based Terumo Corporation and WEGO Terumo (Weihai) Medical Products CO., Ltd., received the National Medical Products Administration (NMPA) approval to market and manufacture the first neutralized peritoneal dialysis solution in the country. Such partnerships play a critical role in fueling the hemodialysis and peritoneal dialysis market growth.
The growing convergence of digital and artificial intelligence enabled devices is also expected to boost market growth. With government and private initiatives, there is high emphasis on educating the healthcare professionals to properly use modern technology.
China Hemodialysis and Peritoneal Dialysis Market Segmentation
The EMR’s report titled “Hemodialysis and Peritoneal Dialysis Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Hemodialysis
- Peritoneal Dialysis
Market Breakup by Product and Services
- Equipment
- Consumables
- Drugs
- Services
- In-Center Dialysis
- Home Dialysis
- Shanghai
- Zhejiang
- Guangdong
- Jiangsu
- Beijing
The China hemodialysis and peritoneal dialysis market demand is being driven by the rising health concerns among consumers, the growing disposable incomes, and the rapidly emerging economies within the region. With the advent of minimally invasive tools, the patient volume has been relatively higher owing to convenient procedures and faster recovery period.
With a significant rise in healthcare investments, there has been a notable increase in the number of dialysis centers in China. The segment of hemodialysis will hold the largest share in the market, primarily due to greater accessibility of HD centers, an increasing number of public dialysis centers, increased knowledge and understanding of the management of HD, reimbursement coverage, and socio-demographic factors. In addition, the growing focus of key players for expanding their business in the country will boost the hemodialysis and peritoneal dialysis market share globally as well.
China Hemodialysis and Peritoneal Dialysis Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Asahi Kasei Medical Co., ltd.
- Shandong Weigao Group Medical Polymer Company Limited
- Shenzhen Landwind Industry Co., Ltd.
- Baxter International Inc.
- B.Braun Melsungen AG
- Davita Healthcare Partners Inc.
- Fresenius Medical Care AG & Co. KGaA
- Nikkiso Co., Ltd.
- Nipro Corporation
- NxStage Medical, Inc.
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
200 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 China Hemodialysis and Peritoneal Dialysis Market Overview
- 3.1 China Hemodialysis and Peritoneal Dialysis Market Historical Value (2018-2024)
- 3.2 China Hemodialysis and Peritoneal Dialysis Market Forecast Value (2025-2034)
- 4 China Hemodialysis and Peritoneal Dialysis Market Landscape
- 4.1 China Hemodialysis and Peritoneal Dialysis Developers’ Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 China Hemodialysis and Peritoneal Dialysis Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 5 China Hemodialysis and Peritoneal Dialysis Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 China Hemodialysis and Peritoneal Dialysis Market Segmentation
- 6.1 China Hemodialysis and Peritoneal Dialysis Market by Type
- 6.1.1 Market Overview
- 6.1.2 Hemodialysis
- 6.1.2.1 Conventional Hemodialysis
- 6.1.2.2 Daily Hemodialysis
- 6.1.2.3 Nocturnal Hemodialysis
- 6.1.3 Peritoneal Dialysis
- 6.1.3.1 Continuous Ambulatory Peritoneal Dialysis (CAPD)
- 6.1.3.2 Automated Peritoneal Dialysis (APD)
- 6.2 China Hemodialysis and Peritoneal Dialysis Market by Product and Services
- 6.2.1 Market Overview
- 6.2.2 Equipment
- 6.2.2.1 Dialysis Machines
- 6.2.2.2 Dialyzers
- 6.2.2.3 Bloodline Systems
- 6.2.2.4 Others
- 6.2.3 Consumables
- 6.2.3.1 Catheters
- 6.2.3.2 Peritoneal Dialysis Solution
- 6.2.3.3 Bloodline Tubing Sets
- 6.2.3.4 Others
- 6.2.4 Drugs
- 6.2.5 Services
- 6.3 China Hemodialysis and Peritoneal Dialysis Market by Dialysis Site
- 6.3.1 Market Overview
- 6.3.2 In-Center Dialysis
- 6.3.3 Home Dialysis
- 6.4 China Hemodialysis and Peritoneal Dialysis Market by Region
- 6.4.1 Market by Cities
- 6.4.2 Shanghai
- 6.4.3 Zhejiang
- 6.4.4 Guangdong
- 6.4.5 Jiangsu
- 6.4.6 Beijing
- 7 Shanghai Hemodialysis and Peritoneal Dialysis Market
- 7.1 Hemodialysis and Peritoneal Dialysis Market Historical Value (2018-2024)
- 7.2 Hemodialysis and Peritoneal Dialysis Market Forecast Value (2025-2034)
- 7.3 Hemodialysis and Peritoneal Dialysis Market by Type
- 7.4 Hemodialysis and Peritoneal Dialysis Market by Dialysis Site
- 8 Zhejiang Hemodialysis and Peritoneal Dialysis Market
- 8.1 Hemodialysis and Peritoneal Dialysis Market Historical Value (2018-2024)
- 8.2 Hemodialysis and Peritoneal Dialysis Market Forecast Value (2025-2034)
- 8.3 Hemodialysis and Peritoneal Dialysis Market by Type
- 8.4 Hemodialysis and Peritoneal Dialysis Market by Dialysis Site
- 9 Guangdong Hemodialysis and Peritoneal Dialysis Market
- 9.1 Hemodialysis and Peritoneal Dialysis Market Historical Value (2018-2024)
- 9.2 Hemodialysis and Peritoneal Dialysis Market Forecast Value (2025-2034)
- 9.3 Hemodialysis and Peritoneal Dialysis Market by Type
- 9.4 Hemodialysis and Peritoneal Dialysis Market by Dialysis Site
- 10 Jiangsu Hemodialysis and Peritoneal Dialysis Market
- 10.1 Hemodialysis and Peritoneal Dialysis Market Historical Value (2018-2024)
- 10.2 Hemodialysis and Peritoneal Dialysis Market Forecast Value (2025-2034)
- 10.3 Hemodialysis and Peritoneal Dialysis Market by Type
- 10.4 Hemodialysis and Peritoneal Dialysis Market by Dialysis Site
- 11 Beijing Hemodialysis and Peritoneal Dialysis Market
- 11.1 Hemodialysis and Peritoneal Dialysis Market Historical Value (2018-2024)
- 11.2 Hemodialysis and Peritoneal Dialysis Market Forecast Value (2025-2034)
- 11.3 Hemodialysis and Peritoneal Dialysis Market by Type
- 11.4 Hemodialysis and Peritoneal Dialysis Market by Dialysis Site
- 12 Funding and Investment Analysis
- 12.1 Analysis by Funding Instances
- 12.2 Analysis by Type of Funding
- 12.3 Analysis by Funding Amount
- 12.4 Analysis by Leading Players
- 12.5 Analysis by Leading Investors
- 12.6 Analysis by Geography
- 13 Partnership and Collaborations Analysis
- 13.1 Analysis by Partnership Instances
- 13.2 Analysis by Type of Partnership
- 13.3 Analysis by Leading Players
- 13.4 Analysis by Geography
- 14 Regulatory Framework
- 15 Supplier Landscape
- 15.1 Asahi Kasei Medical Co., ltd.
- 15.1.1 Financial Analysis
- 15.1.2 Product Portfolio
- 15.1.3 Demographic Reach and Achievements
- 15.1.4 Mergers and Acquisitions
- 15.1.5 Certifications
- 15.2 Shandong Weigao Group Medical Polymer Company Limited
- 15.2.1 Financial Analysis
- 15.2.2 Product Portfolio
- 15.2.3 Demographic Reach and Achievements
- 15.2.4 Mergers and Acquisitions
- 15.2.5 Certifications
- 15.3 Shenzhen Landwind Industry Co., Ltd.
- 15.3.1 Financial Analysis
- 15.3.2 Product Portfolio
- 15.3.3 Demographic Reach and Achievements
- 15.3.4 Mergers and Acquisitions
- 15.3.5 Certifications
- 15.4 Baxter International Inc.
- 15.4.1 Financial Analysis
- 15.4.2 Product Portfolio
- 15.4.3 Demographic Reach and Achievements
- 15.4.4 Mergers and Acquisitions
- 15.4.5 Certifications
- 15.5 B.Braun Melsungen AG
- 15.5.1 Financial Analysis
- 15.5.2 Product Portfolio
- 15.5.3 Demographic Reach and Achievements
- 15.5.4 Mergers and Acquisitions
- 15.5.5 Certifications
- 15.6 Davita Healthcare Partners Inc.
- 15.6.1 Financial Analysis
- 15.6.2 Product Portfolio
- 15.6.3 Demographic Reach and Achievements
- 15.6.4 Mergers and Acquisitions
- 15.6.5 Certifications
- 15.7 Fresenius Medical Care AG & Co. KGaA
- 15.7.1 Financial Analysis
- 15.7.2 Product Portfolio
- 15.7.3 Demographic Reach and Achievements
- 15.7.4 Mergers and Acquisitions
- 15.7.5 Certifications
- 15.8 Nikkiso Co., Ltd.
- 15.8.1 Financial Analysis
- 15.8.2 Product Portfolio
- 15.8.3 Demographic Reach and Achievements
- 15.8.4 Mergers and Acquisitions
- 15.8.5 Certifications
- 15.9 Nipro Corporation
- 15.9.1 Financial Analysis
- 15.9.2 Product Portfolio
- 15.9.3 Demographic Reach and Achievements
- 15.9.4 Mergers and Acquisitions
- 15.9.5 Certifications
- 15.10 NxStage Medical, Inc.
- 15.10.1 Financial Analysis
- 15.10.2 Product Portfolio
- 15.10.3 Demographic Reach and Achievements
- 15.10.4 Mergers and Acquisitions
- 15.10.5 Certifications
- 16 China Hemodialysis and Peritoneal Dialysis Market - Distribution Model (Additional Insight)
- 16.1 Overview
- 16.2 Potential Distributors
- 16.3 Key Parameters for Distribution Partner Assessment
- 17 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 18 Company Competitiveness Analysis (Additional Insight)
- 18.1 Very Small Companies
- 18.2 Small Companies
- 18.3 Mid-Sized Companies
- 18.4 Large Companies
- 18.5 Very Large Companies
- 19 Payment Methods (Additional Insight)
- 19.1 Government Funded
- 19.2 Private Insurance
- 19.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.